Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease

Metabolic Brain Disease

Volumn 13, Issue 1, 1998, Pages 43-53

  Gold, Michael ^a   Hauser, Robert A ^a   Chen, Marianne F ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's Disease; Dementia; Parkinson's Disease; Thiamine

Indexed keywords

THIAMINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; ERYTHROCYTE LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; THIAMINE DEFICIENCY; VITAMIN BLOOD LEVEL;

EID: 0031949728     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020678912330     Document Type: Article

References (60)

1. Agbayewa, M.O., Bruce, V.M., and Siemens, V. (1992). Pyridoxine, ascorbic acid and thiamine in Alzheimer and comparison subjects. Can. J. Psy, 37:661-662.
2. Allain, H., Lieury, A., Quemener, V., Thomas, V., Reymann, J. M., and Gandon, J. M. (1995). Procedural Memory and Parkinson's Disease. Dementia, 6:174-178.
3. Bancher, C., Braak, H., Fischer, P., and Jellinger, K.A. (1993). Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's Disease patients. Neurosci. Lett. 162:179-182.
4. Bayles, K.A., and Tomoeda, C.K. (1983). Confrontation naming in dementia. Brain & Language, 19:98-114.
5. Bayles, K.A., Tomoeda, C.K., Wood, J.A., Montgomery, E.B., Cruz, R.F., Azuma, T., and McGeagh, A. (1996). Changes in cognitive function in Idiopathic Parkinson's Disease. Arch. Neurol. 53:1140-1146.
6. Becker, J.T., Boller, F., Lopez, O.L., Saxton, J., and KcGonigle, K.L. (1994). The natural history of Alzheimer's Disease: Description of study cohort and accuracy of diagnosis. Arch. Neurol. 51:585-594.
7. Biggins, C.A., Boyd, J.L., Harrop, F.M., Madeley, P., Mindham, R.H., Randall, J.I., and Spokes, E.G. (1992). A controlled, longitudinal study of dementia in Parkinson's disease. J. Neurol. Neurosurg. Psych. 55:566-571.
8. Blass, J.P., and Gibson, G.E. (1991). The role of oxidative abnormalities in the pathophysiology of Alzheimer's Disease. Rev. Neurol. 147:513-525.
9. Blin, O., Desnuelle, C., Rascol, O., Borg, M., Peyro Saint Paul, H., Azulay, J.P., et al. (1994). Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's Disease and multiple system atrophy. J. Neurol. Sci. 125:95-101.
10. Boller, F., Mizutani, T., Roessmann, U., and Gambetti, P. (1980). Parkinson's Disease, dementia and Alzheimer's Disease: clinicopathological correlations. Ann. Neurol. 7:329-335.
11. Burkhardt, C.R., and Weber, H.K. (1994). Parkinson's Disease: a chronic low-grade anti-oxidant deficiency? Med. Hypotheses 43:111-114.
12. Burns, A., Marsh, A., and Bender, D.A. (1989). Dietary intake and clinical, anthropometric and biochemical indices of malnutrition in elderly demented patients and non-demented subjects. Psychol. Med. 19:383-391.
13. Butterworth, R.F., Kril, J.J., and Harper, C.G. (1993). Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol. Clin. Exp. Res. 17:1084-1088.
14. Calingasan, N.Y., Gandy, S.E., Baker, H., Sheu, K.F., Kim, K.S., Wisniewski, H. M., and Gibson, G.E. (1995). Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency. Brain Res. 677:50-60.
15. Calingasan, N.Y., Gandy, S.E., Baker, H., Sheu, K.F., Smith, J.D., Lamb, B.T., Gearhart et al. (1996). Novel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency. Am. J. Pathol. 149:1063-1071.
16. Candy, J.M., Perry, R.H., Perry, E.K., Irving, D., Blessed, G., Fairbairn, A.F., and Tomlinson, B.E. (1983). Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's Disease. J. Neurol. Sci. 59:277-289.
17. Chen, M.F., Boyce, H.W., Barry, P.P., and Amontrec, J.S. (1986). Blood levels of thiamine in older Americans in relation to the magnesium concentration. Nut. Rep. Int. 33:559-564.
18. Chen, M.F., Chen, L.T., Gold, M., and Boyce, H.W. (1996). Plasma and erythrocyte thiamin concentrations in geriatric out patients. J. Am. Coll. Nut. 15:231-236.
19. Cullen, K.M., and Halliday, G.M. (1995). Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics. Metab. Brain Dis. 10:81-91.
20. Daniel, W.W. (1990). Applied Nonparametric Statistics. (2nd ed.). Boston: PWS-KENT Publishing Company.
21. de Vos, R. A., Jansen, E. N., Stam, F. C., Ravid, R., and Swaab, D. F. (1995). 'Lewy body disease': clinicopathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin. Neurol. Neurosurg. 97:13-22.
22. DiDonato, S., Zeviani, M., Giovaninni, P., Savarese, N., Rimoldi, M., Mariotti, C., et al. (1993). Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's Disease patients. Neurol. 43:2262-2268.
23. Fearnley, J., and Lees, A. (1993). Pathology of Parkinson's Disease. In (D.B. Calne, Ed.), Neurodegenerative Diseases. Philadelphia: W.B. Saunders, pp. 545-554.
24. Fisher, P., Gatterer, G., and Danielczyk, W. (1988). Semantic memory in DAT, MID and parkinsonism. Funct.Neurol. 3:301-307.
25. Folstein, M.F., Folstein, S.E., and McHugh, P.R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psych. Res. 12:189-198.
26. Friedman, A., and Barcikowska, M. (1994). Dementia in Parkinson's disease. Dementia 5:12-16.
27. Gold, M., Chen, M.F., and Johnson, K. (1995). Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type. Arch. Neurol. 52:1081-1086.
28. Hirsch, E.C. (1993). Does oxidative stress participate in nerve cell death in Parkinson's disease? Europ. Neurol. 33, Suppl 1:52-9.
29. Hulette, C., Mirra, S., Wilkinson, W., Heyman, A., Fillenbaum, G., and Clark, C. (1995). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurol. 45:1991-1995.
30. Ikebe, S., Tanaka, M., and Ozawa, T. (1994). Point mutations of mitochondrial genome in Parkinson's disease. Mol. Brain Res. 2:281-295.
31. Jacobs, D.M., Stern, Y., and Mayeux, R. (1997). Dementia in Parkinson's Disease, Huntington's Disease and Other Degenerative Conditions. In (T.E. Feinberg and M.J. Farah, eds.), Behavioral Neurology and Neuropsychology. New York: McGraw-Hill, pp. 579-589.
32. Katzman, R., Galasko, D., Saitoh, T, Thal, L.J., and Hansen, L. (1995). Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain and Cognition 28:259-265.
33. Kazee, A.M., and Han, L.Y. (1995). Cortical Lewy bodies in Alzheimer's disease. Arch. Pathol. Lab. Med. 119:448-453.
34. Kraemer, H.C., Tinklenberg, J., and Yesavage, J.A. (1994). 'How far' vs 'how fast' in Alzheimer's disease. The question revisited. Arch. Neurol. 51:275-279.
35. Laforenza, U., Patrini, C., Poloni, M., Mazzarello, P., Ceroni, M., Gajdusek, D.C., and Garruto, R.M. (1992). Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients. J. Neurol. Sci. 109:156-161.
36. Mastrogiacoma, F., Bettendorff, L., Grisar, T., and Kish, S.J. (1996). Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann. Neurol. 39:585-591.
37. Mastrogiacomo, F., Bergeron, C., and Kish, S.J. (1993). Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J. Neurochem. 61:2007-2014.
38. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurol. 34:939-944.
39. Meador, K., Loring, D., Nichols, M., Zamrini, E., Rivner, M., Posas, H., et al. (1993). Preliminary findings of high-dose thiamine in dementia of Alzheimer's type. J. Geriatric Psych. & Neurol. 6:222-229.
40. Mimori, Y., Katsuoka, H., and Nakamura, S. (1996). Thiamine therapy in Alzheimer's disease. Metab. Brain Dis. 11:89-94.
41. Mizuno, Y., Suzuki, K., and Ohta, S. (1990). Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J. Neurol. Sci. 96:49-57.
42. Mizuno, Y., Ikebe, S., Hattori, N., Nakagawa-Hattori, Y., Mochizuki, H., Tanaka, M., and Ozawa, T. (1995). Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim. Biophys. Acta 1271:265-274.
43. Murray, A.M., Weihmueller, F.B., Marshall, J.F., Hurtig, H.I., Gottleib, G.L., and Joyce, J.N. (1995). Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann. Neurol. 37:300-312.
44. Mytilineou, C., Werner, P., Molinari, S., Di Rocco, A., Cohen, G., and Yahr, M. D. (1994). Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J. Neural Transmission - Parkinsons Disease & Dementia Section, 8:223-228.
45. Nolan, K.A., Black, R.S., Sheu, K.F., Langberg, J., and Blass, J.P. (1991). A trial of thiamine in Alzheimer's disease. Arch. Neurol. 48:81-83.
46. Olanow, C.W., and Arendash, G.W. (1994). Metals and free radicals in neurodegeneration. Current Opinion Neurol. 7:548-558.
47. Paolo, A.M., Troster, A.I., Glatt, S.L., Hubble, J.P., and Koller, W.C. (1995). Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale. J. Geriat. Psych. Neurol. 8:84-188.
48. Piccirilli, M., D'Alessandro, P., Finali, G., and Piccinin, G.L. (1994). Neuropsychological follow-up of parkinsonian patients with and without cognitive impairment. Dementia 5:17-22.
49. Quirion, R. (1993). Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J. Psych. Neurosci. 18:226-234.
50. Rao, V.L., Richardson, J.S., and Butterworth, R.F. (1993). Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease. Brain Res. 631:334-336.
51. Renvall, M.J., Spindler, A.A., Ramsdell, J.W., and Paskvan, M. (1989). Nutritional status of free-living Alzheimer's patients. Am. J. Med. Sci. 298:20-27.
52. Rosen, T.J., Growdon, J.H., and Corkin, S. (1987). Comparison of rates of progression in Alzheimer's disease and Parkinson's disease. J. Neural Transmis. Supplem. 24:105-107.
53. Schapira, A.M., Mann, V.M., Cooper, J.M., Krige, D., Jenner, P.J., and Marsden, C.D. (1992). Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol. 32 Suppl:S116-24.
54. Schulz, J.B., and Beal, M.F. (1994). Mitochondrial dysfunction in movement disorders. Current Opinion Neurol. 7:333-339.
55. Sheu, K.F., Kim, Y.T., Blass, J.P., and Weksler, M.E. (1985). An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17:444-449.
56. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., et al. (1994). Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia [see comments]. Ann. Neurol. 36:348-355.
57. Stern, G. (1996). Parkinson's disease. The apoptosis hypothesis. Adv. Neurol. 69:101-107.
58. Walpole, R.E., and Myers, R.H. (1978). Probability and Statistics for Engineers and Scientists (2nd ed.). New York: MacMillan Publishing Co.
59. Winograd, C.H., Jacobson, D.H., Butterfield, G.E., Cragen, E., Edler, L.A., Taylor, B.S., and Yesavage, J.A. (1991). Nutritional intake in patients with senile dementia of the Alzheimer type. Alzheimer Dis. & Associated Dis. 5:173-180.
60. Wolf-Klein, G.P., and Silverstone, F.A. (1994). Weight loss in Alzheimer's disease: an international review of the literature. Int.Psychogeriat. 6:135-142.